Prokidney share price today

(PROK)

Prokidney share price is $1.51 & ₹128.31 as on 21 Dec 2024, 2.30 'hrs' IST

$1.51

▲

0.05

(3.42%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Prokidney share price in Dollar and Rupees. Guide to invest in Prokidney from India. Also see the sentimental analysis on Indian investors investing in Prokidney. Get details on the Indian mutual funds that are investing in Prokidney. Get Analyst recommendations and forecasts along with all the Prokidney's financials.

Prokidney share price movements

Today's Low: $1.41
Today's High: $1.55
$1.51
6.62%
Downside
Day's Volatility :8.74%
Upside
2.27%
52 Weeks Low: $1.18
52 Weeks High: $4.44
$1.51
21.85%
Downside
52 Weeks Volatility :73.42%
Upside
65.99%

Prokidney Returns

Period	Prokidney Corp	Index (Russel 2000)
3 Months	-31.21%	0.0%
6 Months	-34.63%	0.0%
1 Year	-25.62%	0.0%
3 Years	-84.67%	-19.7%

Prokidney Key Statistics

in dollars & INR

Previous Close	$1.46
Open	$1.42
Today's High	$1.545
Today's Low	$1.41
Market Capitalization	$1.8B
Today's Volume	$1.2M
52 Week High	$4.44
52 Week Low	$1.18
Revenue TTM	$0.0
EBITDA	$-146.0M
Earnings Per Share (EPS)	$-0.54
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-31.34%

How to invest in Prokidney from India?

It is very easy for Indian residents to invest directly in Prokidney from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Prokidney stock in both Indian Rupees (INR) and US Dollars (USD). Search for Prokidney or PROK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Prokidney or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Prokidney shares which would translate to 0.563 fractional shares of Prokidney as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Prokidney, in just a few clicks!

Returns in Prokidney for Indian investors in Rupees

Investment Value

₹1,00,000

Prokidney investment value today

Current value as on today

₹1,27,812

Returns

₹27,812

(+27.81%)

Returns from Prokidney Stock

₹25,616 (false-25.62%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Prokidney

-27%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Prokidney on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -27% less investors are searching Prokidney in the last 30 days versus the previous period.

Global Institutional Holdings in Prokidney

Morgan Stanley - Brokerage Accounts
11.15%
Suvretta Capital Management, LLC
9.64%
Vanguard Group Inc
4.08%
BlackRock Inc
2.86%
Geode Capital Management, LLC
1.72%
Bleichroeder LP
1.44%

Analyst Recommendation on Prokidney

Buy

66%Buy

33%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Prokidney(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Prokidney

What analysts predicted

Upside of 209.05%

Current:

$1.51

Target:

$4.67

Insights on Prokidney

Price Movement
In the last 7 days, PROK stock has moved down by -15.9%
PROK vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 57.7%
PROK vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 107.7%

Prokidney Technicals Summary

Sell

Neutral

Buy

Prokidney is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Prokidney Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Prokidney Corp	-13.22%	-34.63%	-25.62%	-84.67%	-84.85%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Prokidney Corp	NA	NA	NA	-0.59	-0.31	-0.2	NA	-7.66
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Prokidney Corp	Buy	$1.8B	-84.85%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Prokidney

prokidney (nasdaq: prok), a pioneer in the treatment of ckd through innovations in cellular therapy, was founded in 2015 after a decade of research. prokidney’s lead product candidate, react™ (renal autologous cell therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of ckd, but in some cases potentially drive meaningful improvement in kidney function. late-stage ckd, stage 3b - 4, is a key target for react™ therapy. react™ has received regenerative medicine advanced therapy (rmat) designation, as well as fda and ema guidance, supporting its ongoing phase 3 clinical program, which launched in january 2022. for more information, visit www.prokidney.com.

Organization	Prokidney
Employees	163
CEO	Dr. Bruce Culleton M.D.
Industry	Financial

Management People of Prokidney

Name	Title
Dr. Bruce Culleton M.D.	CEO & Director
Dr. Timothy A. Bertram D.V.M., Ph.D.	Founder
Mr. James Coulston CPA	Chief Financial Officer
Mr. Todd C. Girolamo Esq., J.D., M.B.A.	Chief Legal Officer & Secretary
Ms. Anu Biswas	Senior VP of Manufacturing & Operations
Dr. Ulrich Ernst Ph.D.	EVP of Science and Technology
Ms. Carla Poulson	Chief People Officer
Dr. Joseph M. Stavas M.D., M.P.H.	SVP of Clinical Affairs
Dr. Darin J. Weber Ph.D.	Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access
Mr. Nikhil L. Pereira-Kamath	Chief Business Officer

Important FAQs about investing in Prokidney from India :

What is Prokidney share price today?

Prokidney share price today stands at $1.51, Open: $1.42 ; Previous Close: $1.46 ; High: $1.55 ; Low: $1.41 ; 52 Week High: $4.44 ; 52 Week Low: $1.18. The stock opens at $1.42, after a previous close of $1.46. The stock reached a daily high of $1.55 and a low of $1.41, with a 52-week high of $4.44 and a 52-week low of $1.18.

Can Indians buy Prokidney shares?

Yes, Indians can invest in the Prokidney (PROK) from India.

With INDmoney, you can buy Prokidney at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Prokidney at zero transaction cost.

How can I buy Prokidney shares from India?

It is very easy to buy Prokidney from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Prokidney be purchased?

Yes, you can buy fractional shares of Prokidney with INDmoney app.

What are the documents required to start investing in Prokidney stocks?

To start investing in Prokidney, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.